RESEARCH

FDA approves 10 cities across USA to administer MDMA in a Phase 3 clinical trial.

Imperial College of London Centre for Psychedelic Research is studying the effects on Psilocybin and treating Fibromyalgia.

A theory that low doses of psychedelics induce their effects via alterations in the gut microbiome and related pathways to the brain.

Lifetime use of naturalistic psychedelics was associated with a 60% reduced hazard for suicidality.

Psychedelic use resulted in a 14% reduced likelihood of suicidal thinking within the past year, a 29% reduced likelihood of suicide planning

within the past year, and a 36% reduced likelihood of attempting suicide within the past year.

97 clinical trials recruiting volunteer participants.